<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="850">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04418245</url>
  </required_header>
  <id_info>
    <org_study_id>NIMAO/2020/COVID 19-IA/JF-01</org_study_id>
    <nct_id>NCT04418245</nct_id>
  </id_info>
  <brief_title>CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis</brief_title>
  <acronym>COVID 19-IA</acronym>
  <official_title>Identification of Thoracic CT Scan Biomarkers by Deep Learning for Evaluating the Prognosis of Patients With COVID-19 Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesis is that low-dose computed tomography (LDCT) coupled with artificial
      intelligence by deep learning would generate imaging biomarkers linked to the patient's
      short- and medium-term prognosis.

      The purpose of this study is to rapidly make available an early decision-making tool (from
      the first hospital consultation of the patient with symptoms related to SARS-CoV-2) based on
      the integration of several biomarkers (clinical, biological, imaging by thoracic scanner)
      allowing both personalized medicine and better anticipation of the patient's evolution in
      terms of care organization.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vital status</measure>
    <time_frame>Day 8</time_frame>
    <description>Dead/alive</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient requiring more than 3 liters of oxygen to maintain a saturation &gt;95% (intensive care unit or resuscitation department)</measure>
    <time_frame>Day 8</time_frame>
    <description>Yes/no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of lung affected on CT</measure>
    <time_frame>Day 0</time_frame>
    <description>% ground glass and condensation calculated by deep learning</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of lung affected by ground glass opacity on scan</measure>
    <time_frame>Day 0</time_frame>
    <description>% calculated by deep learning</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of lung affected by condensation on scan</measure>
    <time_frame>Day 0</time_frame>
    <description>% calculated by deep learning</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vital status</measure>
    <time_frame>Day 16</time_frame>
    <description>Dead/alive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital status</measure>
    <time_frame>Day 30</time_frame>
    <description>Dead/alive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>Maximum 30 days</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rehospitalization</measure>
    <time_frame>Day 30</time_frame>
    <description>Yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of intubation</measure>
    <time_frame>Day 30</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of lung affected on CT</measure>
    <time_frame>Day 16</time_frame>
    <description>% ground glass and condensation calculated by deep learning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of lung affected by ground glass opacity on scan</measure>
    <time_frame>Day 16</time_frame>
    <description>% calculated by deep learning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of lung affected by condensation on scan</measure>
    <time_frame>Day 16</time_frame>
    <description>% calculated by deep learning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Software operating time</measure>
    <time_frame>End of study (August 2020)</time_frame>
    <description>Speed of image loading and image processing depending of brand of scanner</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein levels</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>mg/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lactate dehydrogenase</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>U/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lymphocytemia</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>g/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>D Dimers level</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>µg/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until onset of symptoms</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time between RT-PCR positive results and first scan</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>Hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>Years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI&gt; 30</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>Yes/no:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical history of cardiovascular disease</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>Yes/no: hypertension, coronary artery disease, congestive heart failure, cardiac arrhythmia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>Yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical history of respiratory disease</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>Yes/no: Chronic obstructive pulmonary disease, chronic respiratory failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical history of immunosuppressed condition</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>Yes/no: steroid use, pre-existing immunological condition, current chemotherapy for cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current or previous history of smoking</measure>
    <time_frame>Admission Day 0</time_frame>
    <description>Yes/no:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calculate a prognostic score from clinical, biological and CT parameters</measure>
    <time_frame>Day 8</time_frame>
    <description>Deep learning algorithm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calculate a prognostic score from clinical and biological parameters only</measure>
    <time_frame>Day 8</time_frame>
    <description>Deep learning algorithm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare receiver operating curves of prognostic scores with and without CT parameters</measure>
    <time_frame>Day 8</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Covid-19</condition>
  <arm_group>
    <arm_group_label>Patients positive for SARS-CoV-2</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Imaging by thoracic scanner</intervention_name>
    <description>Low-dose computed tomography</description>
    <arm_group_label>Patients positive for SARS-CoV-2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized for Covid-19 confirmed by RT-PCR and undergoing CT scan
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients positive for SARS-CoV-2 according to RT-PCR test between 1st March and 31st
             May 2020

          -  Patients undergoing low dose CT scan to establish Covid-19 lung damage

          -  Available for at least 8 days follow-up

        Exclusion Criteria:

        • Patients opposing the retrospective use of their data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien Frandon</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nimes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU la Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nimes</name>
      <address>
        <city>Nîmes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Martinique</name>
      <address>
        <city>Fort-de-France</city>
        <country>Martinique</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Martinique</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 4, 2020</study_first_submitted>
  <study_first_submitted_qc>June 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2020</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>low dose CT scan</keyword>
  <keyword>biomarkers</keyword>
  <keyword>artificial intelligence</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

